A Phase 2 Clinical Study of Pegerythropoietin Injection (RD01) for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis

Condition:   Patient of Anemia in Chronic Renal Failure With Hemodialysis Interventions:   Drug: RD01;   Drug: Recombinant Human Erythropoiesis Injection (CHO cell);   Drug: placebo Sponsor:   Shengzhen Sciprogen Bio-pharmaceutical Co. Ltd Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials